Ferroptosis in the U87MG Human Glioblastoma Cell Line Induces Damage Associated Molecular Phenotypes
Leif Neitzel1,2, Samantha Rea3, Jessica Cornell3
1Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.
Abstract:
Glioblastomas are known as "immune cold" cancers with little induction of damage-associated molecular phenotypes (DAMPS). We previously described the induction of ferroptosis in glioblastoma cells using the small molecule, OGM, a specific inhibitor of GPR68. The ferroptotic cell death pathway has been reported to induce the release of DAMPS. Here, we show that induction of ferroptosis through both Erastin and OGM results in DAMPS in U87MG cells. This suggests that ferroptosis in human glioblastomas may be able to convert them to an "immune hot" cancer, increasing their susceptibility to immunotherapy. These findings highlight the immunogenic potential of causing ferroptosis in glioblastoma as a therapeutic mechanism of action.
Insights
Ferroptosis induction in glioblastoma may convert "immune cold" tumors to "immune hot" by releasing damage-associated molecular phenotypes (DAMPs). This suggests ferroptosis as a therapeutic strategy to enhance glioblastoma immunotherapy susceptibility.
Area of Science:
- Oncology
- Immunology
- Cancer Cell Death
Background:
- Glioblastomas are characterized as "immune cold" tumors, exhibiting minimal induction of damage-associated molecular phenotypes (DAMPs).
- Previous research identified OGM, a GPR68 inhibitor, as capable of inducing ferroptosis in glioblastoma cells.
- The ferroptosis pathway is recognized for its potential to trigger the release of DAMPs.
Purpose of the Study:
- To investigate whether inducing ferroptosis in glioblastoma cells leads to the release of DAMPs.
- To explore the potential of ferroptosis as a mechanism to enhance glioblastoma's immunogenicity.
- To assess the therapeutic implications of ferroptosis induction for glioblastoma immunotherapy.
Main Methods:
- Utilizing U87MG glioblastoma cell line.
- Inducing ferroptosis using Erastin and OGM (GPR68 inhibitor).
- Assessing the release of damage-associated molecular phenotypes (DAMPs) following ferroptosis induction.
Main Results:
- Both Erastin and OGM successfully induced ferroptosis in U87MG glioblastoma cells.
- Ferroptosis induction resulted in the detectable release of DAMPs from the treated cells.
- These findings indicate that ferroptosis can activate immune signaling in glioblastoma models.
Conclusions:
- Inducing ferroptosis in glioblastoma can lead to the release of DAMPs, potentially converting "immune cold" tumors to an "immune hot" state.
- This immunogenic shift may increase glioblastoma susceptibility to immunotherapy.
- Targeting ferroptosis represents a promising therapeutic strategy to enhance the efficacy of glioblastoma treatments.
More Related Videos
07:48Organotypic Hippocampal Slice Cultures As a Model to Study Neuroprotection and Invasiveness of Tumor Cells
Published on: August 27, 2017
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
